July 14, 2020July 14, 2020

Most RIS Patients Likely to Progress to MS Within 10 Years, Study Says

News

More half of people with brain imaging changes akin to multiple sclerosis (MS) go on to develop the disease within 10 years, a global study of those with radiologically ... Read more

July 14, 2020July 14, 2020

Alternative Medicine Popular With MS Patients in US Northwest, Survey Finds

News

Complementary and alternative medicines are increasingly popular among people with multiple sclerosis (MS) in the northwestern United States, a survey found. More than 80% of the 1,000 people who responded ... Read more

July 13, 2020July 13, 2020

Progentec Signs Agreements to Develop, Commercialize MS Technologies

News

Progentec has established new licensing agreements with Stanford University and the Oklahoma Medical Research Foundation to commercialize and sell laboratory technologies related to multiple sclerosis (MS), the company announced. The ... Read more

July 13, 2020July 13, 2020

University of Sydney Awarded AU$7.1M in Pursuit of Better MS, Mental Health Treatment

News

The Australian Government’s Medical Research Future Fund (MRFF) has awarded AU$7.1 million (about $4.95 million) to support two projects focused on harnessing the power of artificial intelligence (AI) and ... Read more

July 10, 2020July 10, 2020

Trial of Cannabis Derivatives in Treating MS Spasticity to Open in Canada

News

The Multiple Sclerosis Society of Canada and its partner, the Canadian Institutes of Health Research (CIHR), have invested CA$1.5 million to open a clinical trial that will investigate the potential ... Read more

July 10, 2020July 10, 2020

MS Imaging Startup Among 8 Minority-owned Firms Earning Investment

News

JuneBrain, a startup company that is developing a wearable head imaging device that enables multiple sclerosis (MS) patients to remotely monitor their disease activity and treatment response, has received a ... Read more

July 9, 2020July 9, 2020

B-Cells Infected by Epstein-Barr Virus Linked to MS Relapse Risk in Study

News

Immune B-cells that proliferate unchecked when infected by the Epstein-Barr virus (EBV) appear to increase the risk of relapses in patients with multiple sclerosis (MS), a mouse study suggests. The ... Read more

July 9, 2020July 10, 2020

Disability Builds in Relapsing MS in Ways Not Tied to Relapses, Analysis Finds

News

Disability appears to mostly accumulate in people with relapsing forms of multiple sclerosis (MS) in a progressive manner — rather than being due to relapses, a pooled analysis of ... Read more

July 8, 2020July 8, 2020

BMS, Dragonfly Working on Immune System-targeting Therapies for MS

News

Dragonfly Therapeutics and Bristol Myers Squibb (BMS) announced an expanded partnership focused on discovering and developing treatment candidates for multiple sclerosis (MS) and neuroinflammation targets. The companies have been working ... Read more

July 8, 2020July 9, 2020

Switch from Tysabri to Ocrevus Seen as Safe, Effective in RRMS Patients in Small Study

News

Switching to Ocrevus (ocrelizumab) within a relatively short period is a safe and effective option for people with relapsing-remitting multiple sclerosis (RRMS) who stop treatment with Tysabri (natalizumab), a small and retrospective ... Read more

July 7, 2020July 8, 2020

Study: Mavenclad Shows Long-term Effectiveness at Preventing MS Relapses, Disease Progression

News

Mavenclad (cladribine) prevents relapses and disease progression in more than half of patients with relapsing forms of multiple sclerosis (MS) for at least five years after the last dose, according ... Read more

July 7, 2020July 7, 2020

Collaborative Project Will Focus on TRPM4 as Potential Therapeutic Target for MS

News

The German Federal Ministry of Education and Research (BMBF) has granted €1.2 million ($1.35 million) to support a project seeking to characterize the function of the protein TRPM4, a ... Read more

July 6, 2020July 6, 2020

Higher BMI as Teenagers Raises Risk of MS for Men, Study Finds

News

Young men, ages 16 to 20, with a higher the body mass index (BMI) are at greater their risk of being diagnosed with multiple sclerosis (MS) later in life, ... Read more

July 6, 2020July 6, 2020

Tecfidera Safe and Effective in Hispanic/Latino MS Patients, Real-world Data Show

News

Tecfidera (dimethyl fumarate) is as safe and effective in Hispanic/Latino multiple sclerosis (MS) patients as it is in their non-Hispanic and non-Latino peers, three-year data from a real-world study show. These interim ... Read more

July 2, 2020July 2, 2020

PROTXX, University of Alberta Collaborate to Develop Remote Healthcare Platform for MS Patients

News

The University of Alberta and PROTXX are collaborating to develop wearable sensors for people with multiple sclerosis (MS) and advance a remote healthcare platform that facilitates personalized care and reduces frequency ... Read more

July 2, 2020July 2, 2020

Osmotica Amends NDA for Arbaclofen ER to Treat MS Spasticity

News

Osmotica Pharmaceuticals has submitted an amended new drug application (NDA) to the U.S. Food and Drug Administration (FDA) requesting the approval of arbaclofen extended release (ER) tablets for the ... Read more

July 1, 2020July 1, 2020

Anxiety and Depression Linked to RRMS Relapse Risk, Study Finds

News

Comorbidities such as anxiety and depression are associated with a significantly increased risk of relapse in people with relapsing-remitting multiple sclerosis (RRMS), a clinical trial analysis has found.  Anxiety ... Read more

July 1, 2020July 1, 2020

Exposure to DMTs Does Not Increase Risk of Severe COVID-19 in MS Patients, Study Finds

News

Exposure to disease-modifying therapies does not increase multiple sclerosis (MS) patients’ risk of developing a severe form of COVID-19, according to a registry-based study. However, MS patients who are older, ... Read more